Department of Urology, University Hospital Frankfurt, Frankfurt, Germany.
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
Urol Int. 2021;105(11-12):1104-1112. doi: 10.1159/000518066. Epub 2021 Aug 18.
Females with in-hospital treatment for acute cystitis (AC) or pyelonephritis may benefit from catheterization at admission.
All female patients with AC or pyelonephritis requiring in-hospital treatment at University Hospital Frankfurt (2004-2019) were retrospectively analyzed. Logistic regression models were used to predict the catheter value.
Of 310 female patients, 40% harbored AC versus 60% pyelonephritis, of whom 62% and 74% received a catheter at admission: C-reactive protein (CRP) and white blood count (WBC) were significantly elevated in AC and pyelonephritis catheter versus no catheter patients (both p < 0.05). Time to CRP and WBC nadir did not differ between the AC catheter versus no catheter group (both p > 0.05). Conversely, time to CRP nadir was prolonged in pyelonephritis catheter patients. AC and pyelonephritis catheter patients exhibited a prolonged antibiotic treatment and length of stay (LOS, both p < 0.05). In multivariable analyses, CRP >5 ng/mL was a predictor for receiving a catheter in all patients. In AC, a positive urine culture and fever predicted, respectively, prolonged LOS or antibiotic treatment (all p < 0.05).
Risk factors exist with regard to receiving a catheter and prolonged antibiotic treatment or LOS in females with AC or pyelonephritis. A catheter may not accelerate recovery or WBC nadir.
因急性膀胱炎(AC)或肾盂肾炎住院治疗的女性患者,入院时行导尿可能获益。
回顾性分析法兰克福大学医院(2004-2019 年)所有因 AC 或肾盂肾炎需住院治疗的女性患者。采用逻辑回归模型预测导尿管的应用价值。
310 例女性患者中,40%为 AC,60%为肾盂肾炎,其中 62%和 74%的患者入院时导尿:AC 和肾盂肾炎导尿管组与非导尿管组的 C 反应蛋白(CRP)和白细胞计数(WBC)均显著升高(均 p<0.05)。CRP 和 WBC 达峰时间在 AC 导尿管组与非导尿管组之间无差异(均 p>0.05)。相反,肾盂肾炎导尿管组 CRP 达峰时间延长。AC 和肾盂肾炎导尿管患者的抗生素治疗时间和住院时间均延长(均 p<0.05)。多变量分析显示,CRP>5ng/ml 是所有患者接受导尿管的预测因素。在 AC 中,阳性尿培养和发热分别预测延长 LOS 或抗生素治疗时间(均 p<0.05)。
AC 或肾盂肾炎女性患者接受导尿管治疗及延长抗生素治疗或 LOS 与某些风险因素相关。导尿可能不会加速恢复或降低 WBC 达峰时间。